SCHEMBL30262108

SCHEMBL30262108

CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O

nearest known ligand 0.53

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 4/20 0.53
▸ CALCR P30988 11/20 0.53
▸ HCRTR1 O43613 1/20 0.52
▸ HCRTR2 O43614 1/20 0.52
▸ RAMP3 O60896 7/20 0.51
▸ CRHR1 P34998 1/20 0.49
▸ CRHR2 Q13324 1/20 0.49
▸ MC4R P32245 1/20 0.47
▸ NMBR P28336 1/20 0.46
▸ GRPR P30550 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30862331 0.86 CALCR (0.65) F2CALCRHCRTR1HCRTR2CRHR1
SCHEMBL30827588 0.83 MC4R (0.47) F2CALCRHCRTR1HCRTR2MC4R
SCHEMBL31182995 0.83 CALCR (0.63) F2CALCRHCRTR1HCRTR2RAMP3
SCHEMBL30432828 0.83 CALCR (0.59) F2CALCRHCRTR1HCRTR2CRHR1
SCHEMBL31182490 0.82 CRHR1 (0.63) F2CALCRHCRTR1HCRTR2RAMP3
SCHEMBL29903339 0.82 CALCR (0.58) F2CALCRHCRTR1HCRTR2CRHR1
SCHEMBL31182805 0.82 CALCR (0.67) F2CALCRHCRTR1HCRTR2CRHR1
SCHEMBL30272450 0.82 F2 (0.46) F2CALCRMC4R
SCHEMBL30382454 0.82 F2 (0.52) F2CALCRHCRTR1HCRTR2CRHR1
SCHEMBL31031519 0.81 CALCR (0.55) F2CALCRHCRTR1HCRTR2CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040544-A1 COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) SAREPTA THERAPEUTICS, INC. 2023-02-09 — — US disclosed
Send feedback